Results 271 to 280 of about 2,670,563 (294)
Some of the next articles are maybe not open access.

Targeting Endocrine Resistance: Is There a Role for mTOR Inhibition?

Clinical Breast Cancer, 2010
The phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway is a critical intracellular signaling cascade that mediates both growth factor-induced proliferation and cell survival with deregulated signaling through this pathway, a feature of most cancers.
Amna, Sheri   +2 more
openaire   +2 more sources

Response and Resistance to the Endocrine Prevention of Breast Cancer

2008
The data from observational studies and clinical trials indicates that it is possible to prevent BC for prolonged periods using various endocrine manipulations. Ovarian suppression is thought to give lifelong protection and recent data indicate that the effectiveness of Tam continues after cessation of treatment at 5-8 years.
Anthony, Howell   +4 more
openaire   +2 more sources

Glucocorticoid-resistant forms of endocrine ophthalmopathy

Russian Annals of Ophthalmology
Endocrine ophthalmopathy (EO; also called Graves’ ophthalmopathy, thyroid eye disease) is a common extrathyroidal manifestation of Graves’ disease, characterized by the presence of autoimmune inflammatory process in the orbital soft tissues. The prevalence of EO is approximately 10 cases per 10.000 population, higher in individuals over 50 years old ...
openaire   +2 more sources

RESISTANCE AND THE ENDOCRINES

Southern Medical Journal, 1951
M Y Dabney   +3 more
openaire   +1 more source

Endocrine Response to Resistance Training in Children

Pediatric Exercise Science, 2014
Bareket, Falk, Alon, Eliakim
openaire   +2 more sources

Resistance to endocrine therapy A panel discussion

Breast Cancer Research and Treatment, 1987
W L, McGuire   +3 more
openaire   +2 more sources

ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancer

Nature Reviews Clinical Oncology, 2015
Rinath Jeselsohn   +2 more
exaly  

Medullary thyroid carcinoma: A component of an interesting endocrine syndrome

Ca-A Cancer Journal for Clinicians, 1969
Melvin A Block
exaly  

Home - About - Disclaimer - Privacy